Re: Olaparib Combined with Abiraterone in Patients with Metastatic Castration-Resistant Prostate Cancer: A Randomised, Double-Blind, Placebo-Controlled, Phase 2 Trial

Samir S. Taneja

Research output: Contribution to journalComment/debatepeer-review

Original languageEnglish (US)
Pages (from-to)667
Number of pages1
JournalJournal of Urology
Volume201
Issue number4
DOIs
StatePublished - 2019

ASJC Scopus subject areas

  • Urology

Cite this